RU2014119143A - APPLICATION OF SEMAX PEPTIDE (AKTG4-7-Pro-Gly-Pro) TO IMPROVE THE COURSE OF MYOCARDIAL REMODELING AFTER INFARCTION - Google Patents

APPLICATION OF SEMAX PEPTIDE (AKTG4-7-Pro-Gly-Pro) TO IMPROVE THE COURSE OF MYOCARDIAL REMODELING AFTER INFARCTION Download PDF

Info

Publication number
RU2014119143A
RU2014119143A RU2014119143/15A RU2014119143A RU2014119143A RU 2014119143 A RU2014119143 A RU 2014119143A RU 2014119143/15 A RU2014119143/15 A RU 2014119143/15A RU 2014119143 A RU2014119143 A RU 2014119143A RU 2014119143 A RU2014119143 A RU 2014119143A
Authority
RU
Russia
Prior art keywords
pro
aktg4
gly
infarction
course
Prior art date
Application number
RU2014119143/15A
Other languages
Russian (ru)
Inventor
Светлана Анатольевна Гаврилова
Анна Валерьевна Голубева
Александр Берикович Бердалин
Мария Павловна Морозова
Сергей Валентинович Буравков
Владимир Борисович Кошелев
Людмила Александровна Андреева
Original Assignee
Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) filed Critical Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)
Priority to RU2014119143/15A priority Critical patent/RU2014119143A/en
Publication of RU2014119143A publication Critical patent/RU2014119143A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Применение пептида Семакс (AKTГ4-7-Pro-Gly-Pro) в острую стадию инфаркта миокарда с целью благоприятного влияния на последующее ремоделирование сердечной мышцы.The use of the Semax peptide (AKTG4-7-Pro-Gly-Pro) in the acute stage of myocardial infarction in order to favorably influence the subsequent remodeling of the heart muscle.

Claims (1)

Применение пептида Семакс (AKTГ4-7-Pro-Gly-Pro) в острую стадию инфаркта миокарда с целью благоприятного влияния на последующее ремоделирование сердечной мышцы. The use of the Semax peptide (AKTG4-7-Pro-Gly-Pro) in the acute stage of myocardial infarction in order to favorably influence the subsequent remodeling of the heart muscle.
RU2014119143/15A 2014-05-13 2014-05-13 APPLICATION OF SEMAX PEPTIDE (AKTG4-7-Pro-Gly-Pro) TO IMPROVE THE COURSE OF MYOCARDIAL REMODELING AFTER INFARCTION RU2014119143A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014119143/15A RU2014119143A (en) 2014-05-13 2014-05-13 APPLICATION OF SEMAX PEPTIDE (AKTG4-7-Pro-Gly-Pro) TO IMPROVE THE COURSE OF MYOCARDIAL REMODELING AFTER INFARCTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014119143/15A RU2014119143A (en) 2014-05-13 2014-05-13 APPLICATION OF SEMAX PEPTIDE (AKTG4-7-Pro-Gly-Pro) TO IMPROVE THE COURSE OF MYOCARDIAL REMODELING AFTER INFARCTION

Publications (1)

Publication Number Publication Date
RU2014119143A true RU2014119143A (en) 2015-11-20

Family

ID=54552985

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014119143/15A RU2014119143A (en) 2014-05-13 2014-05-13 APPLICATION OF SEMAX PEPTIDE (AKTG4-7-Pro-Gly-Pro) TO IMPROVE THE COURSE OF MYOCARDIAL REMODELING AFTER INFARCTION

Country Status (1)

Country Link
RU (1) RU2014119143A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2666937C1 (en) * 2017-09-27 2018-09-13 Объединенный Институт Ядерных Исследований (Оияи) Method for preventing reduction of muscular force in acute radiation injury in experiment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2666937C1 (en) * 2017-09-27 2018-09-13 Объединенный Институт Ядерных Исследований (Оияи) Method for preventing reduction of muscular force in acute radiation injury in experiment

Similar Documents

Publication Publication Date Title
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
TWD174626S (en) Cabinet
EA201691991A1 (en) MULTI-SPECIFIC ANTIBODIES
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
EA201692254A1 (en) IMMUNOMODULATING PROGENATIVE (IMP) CELLS
EA201692529A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISORDERS USING FOLLYSTATINE POLYPEPTIDES
BR112017000456A2 (en) topical antiviral compositions and methods of use thereof
TWD170026S (en) Vessel
MX395231B (en) COMPOUNDS EFFECTIVE IN THE TREATMENT OF HEPATOTOXICITY AND FATTY LIVER DISEASES, AND THEIR USE.
EA201692552A1 (en) MODIFIED MENICOCCOKED POLYPEPTIDES fHbp
EP3691664A4 (en) MANIPULATION OF TRYPTAMINE METABOLISM
EA201691429A1 (en) MODIFIED MENICOCCOKED POLYPEPTIDES fHbp
MX2016009590A (en) APILIMOD COMPOSITIONS AND METHODS TO USE THE SAME.
MX2017006019A (en) APILIMOD FOR USE IN THE TREATMENT OF MELANOMA.
WO2016079110A3 (en) Use of enzyme for cleaning
EA201890439A1 (en) IMMUNICOLOGICAL MESODERMAL CELL PRECURIOR (ioMP-CELL)
UY36173A (en) METHOD OF TREATMENT OF DISEASES RELATED TO THE INDICATABLE FACTOR FOR HYPOXIA
EA201692518A3 (en) METHODS TO IMPROVE MYOCARDIAL PERFORMANCE IN PATIENTS AFTER FONTENE OPERATION USING UDENAFIL COMPOSITIONS
PH12016502311A1 (en) Omega-3 analogues
MX394179B (en) LIRAGLUTIDE IN CARDIOVASCULAR DISEASES.
ITUB20152923A1 (en) HIGH RESISTANCE TO ATMOSPHERIC AGENTS.
ECSP18050673A (en) GIBERELIN FORMULATIONS IN CONCENTRATED SOLUTION
RU2014119143A (en) APPLICATION OF SEMAX PEPTIDE (AKTG4-7-Pro-Gly-Pro) TO IMPROVE THE COURSE OF MYOCARDIAL REMODELING AFTER INFARCTION
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis